(Q44415299)

English

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

1

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Alessandra Ferrajoli

8

object named as

Alessandra Ferrajoli

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Srdan Verstovsek

9

object named as

Srdan Verstovsek

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

William G Wierda

10

object named as

William Wierda

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jorge Eduardo Cortes

12

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

object named as

Mary Beth Rios

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

object named as

Francis Giles

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Guillermo Garcia-Manero

7

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Steven M Kornblau

11

object named as

Steven Kornblau

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

object named as

Moshe Talpaz

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Kevin White

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2225-2228

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chronic myelogenous leukemia: biology and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

21 January 2018

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

21 January 2018

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic choices in younger patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11381

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11381

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44415299&oldid=2022438729"